MAP4 and ovarian cancer: The current study sought to assess Syk and MAP4 expression in a large cohort of ovarian cancer specimens, to evaluate associations with patient clinical outcomes and other clinicopathological factors and additionally sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system.